This is the dose studied in clinical trials showing 22.5% average weight loss, so its associated with maximum effectiveness but also potentially the most side effects
UK Legal and Regulatory Considerations Under UK law: These peptides are not licensed as medicines and cannot legally be sold, supplied, or marketed for human or veterinary use without MHRA approval
Note any side effects or injection site reactions
Verma, S., Singh, S.: Current and future status of herbal medicines
Cykliczna struktura Melanotan II powstaje przez utworzenie wizania amidowego midzy acuchem bocznym kwasu asparaginowego (Asp) a acuchem bocznym lizyny (Lys)
Reported issues in practice may include headache, dizziness, nausea, flushing, or changes in sleep pattern (such as vivid dreams or temporary sleep disruption)